Delivery Order SPE2DB22D2103-SPE2DB24FR8UG

Award Date 1/19/24
Potential Completion Date 1/22/24
Potential Value $61K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a Delivery Order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,587.56, is for the supply of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of June 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,286.30, is a delivery order for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $46,074.93, is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,437.94 firm fixed-price delivery order is for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a medication. The contract has an ultimate completion date of January 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,715.82 firm-fixed-price delivery order is for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,642.98 firm fixed-price delivery order is for the pharmaceutical product MYRBETRIQ ER 50 MG TABLET 90S, with a period of performance through July 11, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $6,130.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product, with a period of performance through January 29, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,626.50 firm fixed-price delivery order is for the pharmaceutical product MYRBETRIQ ER 50 MG TABLET 90S, with a performance period through November 15, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $10,819.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a prescription medication. The contract has a firm fixed price and is set to expire on January 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $10,202.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract with a firm fixed price and covers the supply of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2025 and was awarded on February 20, 2025. There is no set-aside designation noted for...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB24FR8UG
    Delivery Order

This federal contract award, valued at $60,636.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product, with a completion date of January 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current award was not designated with a set-aside requirement, indicating open competition.

Generated 5/13/25, 10:22 AM